TABLE 2.
Risk Factors for CA-AKI
| Characteristics | Univariable Odds of CA-AKI (95% CI) | Multivariable Odds of CA-AKI (95% CI) |
|---|---|---|
| Contrast administration | 0.97 (0.43–2.20) | 0.97 (0.40–2.36) |
| Age, y | 1.01 (0.98–1.03) | 1.00 (0.97–1.03) |
| Female | 1.23 (0.60–2.53) | 1.24 (0.55–2.79) |
| Race/Ethnicity | ||
| Black | 1.02 (0.45–2.32) | 1.07 (0.43–2.65) |
| White | Reference | Reference |
| Other | 0.27 (0.07–1.05) | 0.34 (0.09–1.39) |
| Initial eGFR, mean (SD), mL/min per 1.73 m2 | ||
| 30–59 | 0.77 (0.28–2.11) | 0.40 (0.13–1.22) |
| 60+ | Reference | Reference |
| Comorbidities (%) | ||
| Diabetes mellitus | 1.84 (0.89–3.80) | 1.48 (0.62–3.55) |
| Hypertension | 1.46 (0.65–3.27) | 0.87 (0.33–2.30) |
| CHF | 2.27 (1.09–4.73)* | 1.92 (0.83–4.42) |
| Obesity | 1.46 (0.71–3.02) | 1.08 (0.47–2.49) |
| HIV/AIDS | 0.45 (0.06–3.57) | |
| Renal failure | 2.00 (0.92–4.33) | 1.82 (0.73–4.50) |
CA-AKI: increase in serum creatinine of 0.5 mg/dL or 25% increase in patients with baseline of 0.4 to 4.0 and follow-up of at least 48 h.
*P < 0.05.